Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600479 stock hub

SHA/600479 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600479is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.3B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600479

In the news

Latest news · SHA/600479

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E15.7

P25 23.5P50 41.3P75 83.2

ROE11.7

P25 -0.9P50 4.1P75 8.8

ROIC12.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600479 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

CNY

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	5,270
Employees Change	-65%
Employees Change Percent	-1.22
Enterprise value	CNY 5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000001GX3
Last refreshed	2026-05-10
Market cap	CNY 5.3B
Price	CNY 10.77
Price currency	CNY
Rev Per Employee	681,989.61x
Sector	Healthcare
Sic	2834
Symbol	sha/600479
Website	https://www.qjyy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.81%
EV Earnings	16.32x
EV/EBIT	12.9x
EV/EBITDA	10.15x
EV/FCF	13.97x
EV/Sales	1.4x
FCF yield	6.79%
P/B ratio	1.54x
P/E ratio	15.65x
P/S ratio	1.47x
PE Ratio10 Y	19.32x
PE Ratio3 Y	16.5x
PE Ratio5 Y	15.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.84%
EBITDA Margin	13.04%
FCF margin	10.02%
Gross margin	49.25%
Gross Profit	CNY 1.8B
Gross Profit Growth	4.09%
Gross Profit Growth Q	0%
Gross Profit Growth3 Y	0.62%
Gross Profit Growth5 Y	0.97%
Net Income	CNY 308.1M
Net Income Growth	29.63%
Net Income Growth Q	41.1%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Net Income Growth3 Y	0.18%
Net Income Growth5 Y	0.72%
Pretax Margin	12.58%
Profit Margin	8.57%
Profit Per Employee	CNY 58,471
Profitable Years	25
ROA	4.97
Roa5y	5.02
ROCE	10.96
ROE	11.66
Roe5y	12.53
ROIC	12.15
Roic5y	22.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.52%
Cagr15y	2.75%
Cagr1y	7.42%
Cagr20y	8.68%
Cagr3y	-4.45%
Cagr5y	8.73%
Div CAGR10	11.16%
Div CAGR3	0.94%
Div CAGR5	-18.48%
EPS Growth	19.35
EPS Growth Q	21.53
EPS Growth Quarters	5
EPS Growth Years	1
EPS Growth3 Y	-1.3
EPS Growth5 Y	-0.64
FCF Growth	-10.76%
FCF Growth3 Y	-14.95%
FCF Growth5 Y	-1.06%
OCF Growth	13.13%
OCF Growth10 Y	35.85%
OCF Growth3 Y	-7.16%
OCF Growth5 Y	0.22%
Revenue Growth	-1.1x
Revenue Growth Q	-3.46x
Revenue Growth Years	1x
Revenue Growth3 Y	-3.77x
Revenue Growth5 Y	-0.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.73
Assets	CNY 5.1B
Cash	CNY 666.4M
Current Assets	CNY 2.3B
Current Liabilities	CNY 1.6B
Debt	CNY 62.2M
Debt EBITDA	CNY 0.13
Debt Equity	CNY 0.02
Debt FCF	CNY 0.17
Equity	CNY 3.4B
Liabilities	CNY 1.7B
Long Term Assets	CNY 2.8B
Long Term Liabilities	CNY 120.4M
Net Cash	CNY 604.2M
Net Cash By Market Cap	CNY 11.4
Net Cash Growth	-30.99%
Net Debt EBITDA	CNY -1.29
Net Debt Equity	CNY -0.18
Net Debt FCF	CNY -1.68
Tangible Book Value	CNY 2.9B
Tangible Book Value Per Share	CNY 5.82
WACC	5.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.48
Inventory Turnover	3.8
Net Working Capital	CNY 123.2M
Quick ratio	1.13
Working Capital	CNY 754.4M
Working Capital Turnover	CNY 3.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.61%
Dividend Growth	2.86%
Dividend Growth Years	1%
Dividend per share	CNY 0.36
Dividend Years	21
Dividend Yield	3.34%
Ex Div Date	2025-07-25
Last Dividend	CNY 0.36
Payout Frequency	Annual
Payout Ratio	49.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	28.28%
1Y total return	7.42%
200-day SMA	10.72
3Y total return	-12.78%
50-day SMA	10.8
50-day SMA vs 200-day SMA	50over200
5Y total return	51.98%
All Time High	26.43
All Time High Change	-59.26%
All Time High Date	2015-06-15
All Time Low	1.87
All Time Low Change	477.17%
All Time Low Date	2004-11-30
ATR	0.24
Beta	0.3
Beta1y	0.22
Beta2y	0.41
Ch YTD	6
High	10.84
High52	11.53
High52 Date	2026-02-26
High52ch	-6.59%
Low	10.69
Low52	9.86
Low52 Date	2026-03-23
Low52ch	9.23%
Ma50ch	-0.3%
Price vs 200-day SMA	0.43%
RSI	51.73
RSI Monthly	50.75
RSI Weekly	51.86
Sharpe ratio	0.44x
Sortino ratio	0.91
Total Return	-5.26%
Tr YTD	6
Tr15y	50.24%
Tr1m	0.65%
Tr1w	-0.83%
Tr3m	1.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 389.8M
Operating Income Growth	23.96
Operating Income Growth Q	35.1
Operating Income Growth3 Y	-1.71
Operating Income Growth5 Y	2.51
Operating margin	10.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	314,467,883%
Net Borrowing	-7,000,000
Shares Institutions	11.71%
Shares Out	492,210,016
Shares Qo Q	5.24%
Shares Yo Y	8.61%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 360M
Average Volume	8,528,076.75x
Bv Per Share	6.31
CAPEX	CNY -143M
Ch10y	-14.07
Ch15y	-7.29
Ch1m	0.65
Ch1w	-0.83
Ch1y	3.96
Ch20y	206.8
Ch3m	1.6
Ch3y	-20.93
Ch5y	16.81
Ch6m	-0.19
Change	0.19%
Change From Open	0.19
Close	10.75
Days Gap	0
Depreciation Amortization	78,953,225
Dollar Volume	91,440,649.5
Earnings Date	2026-04-29
EBIT	CNY 389.8M
EBITDA	CNY 468.7M
EPS	CNY 0.69
F Score	5
FCF	CNY 360M
FCF EV Yield	7.16x
FCF Per Share	CNY 0.73
Financing CF	-150,758,591
Fiscal Year End	December
Founded	1,966
Goodwill	14,073,873
Graham Number	9.88026
Graham Upside	-8.26
Income Tax	CNY 64.6M
Investing CF	-632,200,906
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2018-06-15
Last Split Type	Forward
Lynch Fair Value	CNY 3.44
Lynch Upside	-68.06
Ma150	10.63
Ma150ch	1.29%
Ma20	10.69
Ma20ch	0.71%
Net CF	-279,999,181
Next Earnings Date	2026-08-27
Open	10.75
P FCF Ratio	14.73
P OCF Ratio	10.54
Payment Date	2025-07-25
Position In Range	53.33
Ppne	617,350,735
Price Date	2026-05-08
Price EBITDA	CNY 11.31
Ptbv Ratio	1.85
Relative Volume	1.01x
Revenue	3,594,085,245x
Tax By Revenue	1.8x
Tax Rate	14.3%
Tr20y	428.45%
Tr6m	-0.19%
Volume	8,490,311

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600479 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.3%

$0.36 annual per share

Payout ratio

+49.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-18.5%

1 consecutive years of growth

Total shareholder yield

-5.3%

Next ex-dividend date: 2025-07-25

Performance

SHA/600479 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600479?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.7%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+8.6%

Negative means the company is buying back shares.

Technical

SHA/600479 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.7

Neutral momentum band

Price vs 200-day MA

+0.4%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600479

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600479 stock rating?

sha/600479 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600479 analysis?

The full report lives at /stocks/sha/600479/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600479?

The latest report frames sha/600479 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600479 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.